Happy Friday!
Hope your week went well! Are you worried about inflation? How is it impacting your investing decisions and your existing portfolio? For the LPs, how are inflation concerns creeping into your plans? Let me know at cwitkowsky@buyoutsinsider.com.
Big one: Thoma Bravo is engaging in one of the most ambitious fundraising programs this year, targeting more than $27 billion across three funds to target from the largest to smallest sides of the tech market. The targets for Thoma Bravo’s three funds are set, though they don’t yet have hard caps, so that total could go higher. Check it out here on Buyouts.
Comms: TPG made a strategic investment in medical communications business BGB Group amid a surge in demand as biopharma and pharma companies deploy large amounts of capital to develop new therapies and successfully reach their target audience, writes Sarah Pringle on PE Hub today.
BGB works with medical marketing, strategic consulting, digital strategy and execution and promotional advertising. TPG invested in BGB through both its growth fund and its healthcare partners platform. Read it here.
That’s it for me! Have a great weekend. Reach me with thoughts and feedback, tips n’ gossip, The Drama or whatever at cwitkowsky@buyoutsinsider.com or find me on LinkedIn.
Read the full wire commentary on PE Hub...